AKT signaling pathway in invasive ductal carcinoma of the breast: correlation with Erα, ERβ and HER-2 expression
作者： Yuelin Hong , Xiuling Wang , Lina Yi , Jue Zou , Weiqiang Zheng
DOI: 10.1700/667.7781
关键词:
摘要: … of variables including ERa, ERß, HER-2/neu and AKT staining … and HER-2/neu in 110 cases of primary breast carcinoma. … Positive ERa, ERß, pAkt and HER-2/neu expressions were …
sagepub.com
sci-hub.st 参考文章(22)
Surojeet Sengupta, V. Craig Jordan, Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance. Advances in Experimental Medicine and Biology. ,vol. 630, pp. 206- 219 ,(2008) , 10.1007/978-0-387-78818-0_13
Tommaso Simoncini, Ali Hafezi-Moghadam, Derek P. Brazil, Klaus Ley, William W. Chin, James K. Liao, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase Nature. ,vol. 407, pp. 538- 541 ,(2000) , 10.1038/35035131
Zhang Weihua, Sandra Andersson, Guojun Cheng, Evan R. Simpson, Margaret Warner, Jan-Åke Gustafsson, Update on estrogen signaling FEBS Letters. ,vol. 546, pp. 17- 24 ,(2003) , 10.1016/S0014-5793(03)00436-8
Suleiman Massarweh, Rachel Schiff, Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk Endocrine-related Cancer. ,vol. 13, ,(2006) , 10.1677/ERC.1.01273
J. J. Wallin, J. Guan, W. W. Prior, K. A. Edgar, R. Kassees, D. Sampath, M. Belvin, L. S. Friedman, Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. Science Translational Medicine. ,vol. 2, ,(2010) , 10.1126/SCITRANSLMED.3000630
Yoko Omoto, Hidetaka Eguchi, Yuri Yamamoto-Yamaguchi, Shin-ichi Hayashi, Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7 Oncogene. ,vol. 22, pp. 5011- 5020 ,(2003) , 10.1038/SJ.ONC.1206787
Sung-Shin Park, Sung-Won Kim, Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Oncology Reports. ,vol. 18, pp. 139- 143 ,(2007) , 10.3892/OR.18.1.139
L Nakopoulou, The favourable prognostic value of oestrogen receptor immunohistochemical expression in breast cancer Journal of Clinical Pathology. ,vol. 57, pp. 523- 528 ,(2004) , 10.1136/JCP.2003.008599
Eriko Tokunaga, Akemi Kataoka, Yasue Kimura, Eiji Oki, Kojiro Mashino, Kojiro Nishida, Tadashi Koga, Masaru Morita, Yoshihiro Kakeji, Hideo Baba, Shinji Ohno, Yoshihiko Maehara, None, The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. European Journal of Cancer. ,vol. 42, pp. 629- 635 ,(2006) , 10.1016/J.EJCA.2005.11.025
Eriko Tokunaga, Yasue Kimura, Eiji Oki, Naoyuki Ueda, Motonori Futatsugi, Kojiro Mashino, Manabu Yamamoto, Masahiko Ikebe, Yoshihiro Kakeji, Hideo Baba, Yoshihiko Maehara, None, Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients International Journal of Cancer. ,vol. 118, pp. 284- 289 ,(2006) , 10.1002/IJC.21358